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LETTER TO THE EDITOR
Reply to the letter from Drs Pollock and Vickers
Sir - We thank Drs Pollock and Vickers for their interest in
our study and were pleased to learn that their findings were
in agreement with our own. A number of their comments
require clarification.
It is important to distinguish between reliability and
validity. In our study data were independently abstracted
from patients' records first by a cancer registry clerk and at a
later date by a researcher. The reliability of abstraction was
examined by comparing the two sets of data which were
appropriately analysed by estimation of the kappa statistic.
Pollock and Vickers appear to assume that abstraction by an
independent researcher acts as a reference method, but an
experienced cancer registry clerk might well be a more
reliable data abstractor than a less experienced researcher.
Some of the differences between the results of the two
studies might be explained by the different tumour sites
investigated. In our study we reported that 'because the cases
were selected according to confirmed data of diagnosis, a
valid comparison could not be made for this variable'. The
changing regulations concerning the registration of superficial
bladder tumours before 1982 (the index year of our study)
was one factor which contributed to the number of ex-
clusions. The data which were reported appeared to show
greater reliability of registration for date of diagnosis for
bladder cancer than for colorectal cancer. Bladder cancer is
almost invariably diagnosed at the patient's first cystoscopy
while the greater variability in the clinical presentation and
initial management of colorectal cancer might contribute to
imprecision in the definition of the date of diagnosis. The
impact of any error in recording date of diagnosis needs to
be considered; in our study the median difference between the
two sets of data was close to zero. Patients with bladder
cancer may be treated with intravesical as well as systemic
chemotherapy. The former may be first administered several
years after initial diagnosis and these late treatments will not
be recorded systematically by the cancer registry under the
6 month rule. Thus the completeness of recording of treat-
ment may also vary according to tumour site.
Although our study showed that information which is
easily abstracted from patients' records is generally reliably
recorded by the cancer registry, we endorse the need to
monitor the quality of cancer registry data. Cancer registra-
tions are a valuable source of information for public health
research and health service management. Registries should be
provided with the resources needed to maintain and audit the
quality of their work.
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